BioSpace News Archive

Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2020.

Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, will report fourth quarter and full year 2020 financial results after market close on Thursday, February 25, 2021

New talent and promotions span core businesses, transformation, IT, revenue cycle management, business development, marketing, legal

Sangamo Therapeutics, Inc., a genomic medicine company, announced that management will be participating in the following investor conferences

MedAvail to Present at the Cowen 41 st Annual Health Care Conference

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the 10th Annual SVB Leerink Global Healthcare Conference as follows: Date: Wednesday, February 24, 2021 Time: 9:20 a.m. Eastern Time Webcast: https://wsw.com/webcast/svbleerink47/osmt/269

MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the fourth quarter and full year ended December 31, 2020 after the market closes on Thursday, February 25, 2021. MacroGenics will host a conference call to discuss the financial results and r

The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its fourth quarter and fiscal year 2020 financial results on Wednesday, February 24, 2021. Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Thursday, February 25, 2021, at 10:00 a.m. Mountain Time (12:

Agreement with the Amsterdam Skills Centre Establishes Second European Surgical Training Site for Senhance Digital Laparoscopy

Genemarkers LLC, leaders in genomic research from Kalamazoo, MI and Swift Biosciences, pioneers in the development of DNA and RNA library preparation kits for Next-Generation Sequencing systems in Ann Arbor, MI, collaborated together to detect mutations and variants from COVID-19 samples sourced in Kalamazoo, MI.